Cooper Companies, Inc.
Close on Nov 19, 2026Market cap $11.47BP/E 20.6Yield –
Cooper Companies Planned/Actual Patient Enrollment in Studies Started by Year
Cooper Companies Planned/Actual Patient Enrollment in Studies Started: 338 in FY2026, down 50.6% from a year earlier. That is the lowest of the 11 years on record here.
Where the FY2026 figure comes from
Source: U.S. National Library of Medicine — ClinicalTrials.gov Registry ↗
annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Cooper Companies Planned/Actual Patient Enrollment in Studies Started, annual FY2016–FY2026 [Data set]. Compiled from Cooper Companies SEC filings and investor materials. https://stockdatahq.com/stocks/coo/kpis/ct-enrollment
See every metric in the Cooper Companies KPI table. Data updated Nov 18, 2026.
See a number that looks wrong?